Almenoff June Sherie

CIK 00014926477 companiesCHAPEL HILL, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001492647

Recent Transactions

50 trades

Award
TENAX THERAPEUTICS, INC.$TENX
Stock Option (right to buy)
2026-01-09+30,000→ 30,000 total
Purchase
TENAX THERAPEUTICS, INC.$TENX
Common Stock
2025-11-18$7.52/sh+1,900→ 1,993 total
Purchase
TENAX THERAPEUTICS, INC.$TENX
Common Stock
2025-11-18$7.52/sh+1,900→ 1,993 total
Purchase
TENAX THERAPEUTICS, INC.$TENX
Common Stock
2025-11-17$7.15/sh+93→ 93 total
Purchase
TENAX THERAPEUTICS, INC.$TENX
Common Stock
2025-11-17$7.15/sh+93→ 93 total
Award
TENAX THERAPEUTICS, INC.$TENX
Stock Option (right to buy)
2025-07-01+80,000→ 80,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2025-06-17+20,100→ 20,100 total
Disposition to Issuer
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2025-03-31−50,000→ 0 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2025-03-28+3,167→ 3,167 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Restricted Stock Units
2025-03-28−3,167→ 6,333 total
Award
TENAX THERAPEUTICS, INC.$TENX
Stock Option (right to buy)
2024-12-10+100,000→ 100,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2024-11-13$13.00/sh+500→ 1,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2024-11-12$12.50/sh+500→ 500 total
Award
Actinium Pharmaceuticals, Inc.$ATNM
Stock Option (Right to Buy)
2024-11-01+50,000→ 50,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Restricted Stock Units
2024-08-13+9,500→ 9,500 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2024-08-13+24,600→ 24,600 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2023-12-20+3,334→ 3,334 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2023-06-30+4,575→ 4,575 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2023-03-31+1,167→ 1,167 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-12-30+410→ 410 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-09-30+605→ 605 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-06-30+4,338→ 4,338 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-06-14+40,000→ 40,000 total
Award
TENAX THERAPEUTICS, INC.$TENX
Stock Option (right to buy)
2022-06-09+5,000→ 5,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-03-31+2,985→ 2,985 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-12-31+737→ 737 total
Award
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2021-12-15+2,000→ 6,000 total
Award
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2021-12-10+2,000→ 4,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-11-10+80,000→ 80,000 total
Award
TENAX THERAPEUTICS, INC.$TENX
Stock Option (right to buy)
2021-06-10+6,250→ 6,250 total
Award
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2019-12-12+2,000→ 2,000 total
Purchase
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2019-01-04$3.39/sh+1,475→ 7,175 total
Purchase
9 METERS BIOPHARMA, INC.
Common stock
2018-08-27$4.96/sh+253→ 800 total
Purchase
9 METERS BIOPHARMA, INC.
Common stock
2018-08-27$4.94/sh+100→ 900 total
Purchase
9 METERS BIOPHARMA, INC.
Common stock
2018-08-27$4.90/sh+47→ 547 total
Purchase
9 METERS BIOPHARMA, INC.
Common stock
2018-08-24$4.85/sh+500→ 1,400 total
Purchase
9 METERS BIOPHARMA, INC.
Common stock
2018-08-24$4.85/sh+100→ 100 total
Purchase
9 METERS BIOPHARMA, INC.
Common stock
2018-08-24$4.99/sh+400→ 500 total
Award
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2018-03-15$3.50/sh+5,700→ 5,700 total
Purchase
BRAINSTORM CELL THERAPEUTICS INC.$BCLI
Common Stock
2018-03-15$3.50/sh+5,700→ 5,700 total
Award
NeuBase Therapeutics, Inc.
Stock Option (right to buy)
2017-10-16+170,000→ 170,000 total
Award
NeuBase Therapeutics, Inc.
Stock Option (right to buy)
2016-01-07+60,000→ 60,000 total
Award
NeuBase Therapeutics, Inc.
Option
2015-03-10+84,000→ 84,000 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2015-02-06$6.75/sh+6,000→ 16,900 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, $0.0001 par value
2014-09-03$8.05/sh+1,200→ 127,566 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, $0.0001 par value
2014-09-02$8.12/sh+1,000→ 126,366 total
Disposition to Issuer
Furiex Pharmaceuticals, Inc.
Stock Options (to buy)
2014-07-02−83,000→ 0 total
Disposition to Issuer
Furiex Pharmaceuticals, Inc.
Stock Options (to buy)
2014-07-02−27,000→ 0 total
Disposition to Issuer
Furiex Pharmaceuticals, Inc.
Stock Options (to buy)
2014-07-02−21,970→ 0 total
Disposition to Issuer
Furiex Pharmaceuticals, Inc.
Stock Options (to buy)
2014-07-02−6,912→ 0 total

Companies

Recent Filings

Address

101 GLEN LENNOX DRIVE SUITE 300

CHAPEL HILL, NC, 27517

View on SEC.gov